INTRODUCTION
R esearch has shown a significant association between combat experiences, such as having one's life threatened, witnessing someone die or be wounded, firing a weapon, and post deployment mental health conditions like posttraumatic stress disorder (PTSD) (1) (2) (3) . PTSD is a group of psychiatric symptoms that cause significant distress and impairment and are present for Ͼ1 month. Symptoms include: mental reexperiencing of the event; avoidance and numbing of responsiveness to reminders of the event; and persistent arousal, such as hyperarousal (4) . Left untreated, this disorder can incur serious disability across the life span (5, 6) . Rates of self-reported PTSD among previously deployed veterans of Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) are estimated to be approximately 14% to 18% (7) (8) (9) (10) . To date, estimates of confirmed clinician-diagnosed cases of PTSD are not readily available. However, data from the OEF/OIF registry, which includes 324,846 veterans, indicate that approximately 21% of returning veterans utilizing Veterans Affairs (VA) health care have a diagnosis of PTSD, based on the 9th revision of the International Classification of Disease (11, 12) . Seal and colleagues (13) found that 25% of returning OEF/ OIF veterans, utilizing VA services, had mental health diagnoses; 60% of these veterans were initially diagnosed in nonmental healthcare settings, e.g., primary care. This evidence suggests that there is a new generation of veterans who are at significant risk for PTSD and use primary care as their first point of contact for healthcare services.
PTSD and Physical Disease
Empirical evidence (14 -17) supports an association between PTSD and physical health problems among veteran and nonveteran samples. Despite a number of limitations present in previous studies, the association remains consistent. Limitations include: reliance on self-reported measures of PTSD and physical disease; and utilizing symptoms of PTSD as the predictor of disease, rather than the clinical diagnosis of the disorder. Foundational work in this area was based on selfreported PTSD symptoms and/or health indices (18 -21) . More recently, a relationship between PTSD symptoms and lifespan objective health indices, such as primary care provider (PCP)-diagnosed disease and mortality, has been established (22, 23) . For example, in a unique prospective study (22) of heart disease and mortality among Vietnam veterans, it was found that veterans with PTSD were at a significantly greater likelihood of dying from ischemic or atheroscleroticrelated heart disease (including myocardial infarction and congestive heart failure). Researchers (24) examined 1400 Vietnam veterans' medical records 20 years post deployment and found that those with lifetime PTSD showed a 50% to 150% increased risk of circulatory, digestive, musculoskeletal, endocrine-nutritional-metabolic, nervous system, respiratory, and nonsexually transmitted infectious diseases. Increased risk of poorer health persisted even after adjusting for relevant covariates, such as smoking history, substance abuse, age, medical profile, and income. In a study (25) examining post war lifetime medical records of World War II and Korean Conflict veterans, results indicated that a 10-point increase in PTSD symptoms on the Mississippi Scale for Combat-Related PTSD (26) was associated with elevated risk of arterial disease by 27%, gastrointestinal disease by 23%, dermatologic disorders by 18%, and musculoskeletal disorders by 9%. Of particular concern was the finding regarding cardiovascular outcomes; 55% of the veterans with the most severe PTSD symptoms had developed an arterial disorder compared with Ͻ20% veterans with low-to-moderate PTSD symptoms.
There is a paucity of research examining individuals with a diagnosis of PTSD (versus those with PTSD symptoms) and physical disease. In a review of research conducted between 1981 and 2008, only seven studies met both criteria (27) . Of these seven studies, three relied on self-reported disease diagnoses, only four included comparison groups, and no studies included both females and males (27) . Several studies were not included in the review. For example, PTSD has been linked to metabolic syndrome, a condition associated with increased risk of multisymptom disease (endocrine, autoimmune, cardiovascular) in Gulf War veterans (16) . Of veterans with PTSD, 43% met the criteria for metabolic syndrome. Another study (23) compared individuals with and without PTSD (n ϭ 134) on PCP-diagnosed disease outcomes. PTSD diagnosis was associated with an increased odds of circulatory disease and musculoskeletal disease, respectively (odds ratio [OR] ϭ 3.69; 95% confidence interval [CI], 1.25-10.18; OR ϭ 2.96; 95% CI, 1.13-7.76). Although this small sample cannot be generalized to the greater population, results concur with larger studies in this area. As recommended in the literature review, research examining PTSD diagnosis and the prevalence of objective records of disease is greatly needed, especially in the face of mounting PTSD cases in returning OEF/OIF veterans (27) .
A model outlining the effects of PTSD on disease onset and progression posits that PTSD leads to poorer health outcomes through the combined effects of psychological and biological mechanisms (28) . Currently, researchers hypothesize that the influence of PTSD on physical disease may take years to develop, warranting the examination of these relationships in trauma-exposed older individuals (29, 30) . However, recent studies suggested that disease may be related to PTSD in the early years after trauma exposure. For example, among a sample of 2863 OEF/OIF veterans, those with self-reported PTSD symptoms also reported increases in physical symptom complaints, sick visits to primary care, and lower ratings of general health (8) . Recently, researchers (10) found that among OEF/OIF veterans with self-reported PTSD, significant decrements in self-reported general health and physical functioning persisted after adjusting for demographics, health risk behaviors, and chemical exposure. Despite above average health status at enlistment, OEF/OIF veterans who develop PTSD may evidence significant PCP-diagnosed disease, even shortly after they return home. To examine if the relationship between PTSD and physical health problems extends beyond self-reported somatic and functional complaints, we examined PCP diagnoses of both concrete (e.g., circulatory disorders) and ill-defined conditions (e.g., idiopathic symptoms). PTSD and depression are conditions with some overlapping symptoms that have been found to co-occur among primary care patients 30% to 50% of the time (31) . For example, both conditions include symptoms, such as social withdrawal and isolation, poor concentration, and sleep disturbance. Given these overlapping symptoms, it is important to adjust for depression and mood disorders when examining the relationship between PTSD and physical health. Along the same lines, a review (32) of prospective research studies on co-occurring PTSD and substance use disorders reported that individuals with PTSD show a 4.5-time increased risk of substance use disorders. It is possible that these individuals are using substances as a coping mechanism to deal with the presence of distressing PTSD symptoms (33) . By including measurement of PTSD, depression, and substance use disorders, we can better evaluate the unique effects of PTSD on multisystem disease development in the short-term post deployment.
Present Study
This study improved on prior work by using standardized PCP-diagnosed measures of PTSD and disease, including women veterans, and implementing advanced statistical methods to examine these relationships over time. Using survival analyses, we examined the time to onset of physical disease among OEF/OIF veterans in the early years post deployment. One advantage of survival analysis is that it permits the study of time to disease (rather than occurrence or nonoccurrence), allowing for different lengths of follow-up (i.e., observation times). Another advantage is that this method accommodates variables (e.g., PTSD) that vary over time. To our knowledge, this study is the first to examine prospectively PTSD diagnosis and PCP-diagnosed disease prevalence among OEF/OIF veterans in the early post deployment years. We hypothesized that PTSD diagnosis would be associated with an increased risk of early onset physical disease.
METHODS

Participants and Procedure
All participants were OEF/OIF veterans who served in geographical areas that the Department of Defense defines as zones of imminent danger (12) . Specifically, soldiers serving in these regions were exposed to one or more of the following: hostile fire or explosions of hostile mines; threat of death; physical harm or imminent danger due to civil insurrection; civil war; terrorism; or wartime conditions. A potential sample of 4932 veterans, who had separated from military service and who sought primary care treatment within the VA Healthcare Network of Upstate New York (VISN2) during the 6-year study period (September 11, 2001 to December 31, 2007), was identified. We excluded 516 of these individuals for the following reasons: 1) having any war or combat experience before September 11, 2001 (n ϭ 182); and 2) having entered the VA healthcare system before September 11, 2001 (n ϭ 334). The final sample (n ϭ 4416) consisted of veterans, who had been deployed to Iraq
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or Afghanistan, separated from military service, and then sought medical care at the VA all within the 6-year study period (Table 1) . Following a prospective research design, participants were sequentially enrolled into the study on their first visit to VA primary care services and were then followed until December 31, 2007. Participant records were extracted electronically from the VISN 2 clinical database, using the FILEMAN software. All extracted data were deidentified. The Institutional Review Board of the Syracuse VA Medical Center approved this project.
For the purpose of analyses, each OEF/OIF veteran in the database was assigned an index date corresponding to his/her first post deployment medical visit to a VA Hospital or care center in VISN 2. This date is the participant's baseline assessment and marks enrollment in the study. Participants were followed from their baseline medical assessment across all subsequent medical visits until the end of the study period, December 31, 2007. Baseline characteristics, such as age, gender, marital status, and unit type, were recorded from the participant's medical file.
Mental and Medical Diagnoses
As standard practice at VA clinics, PCPs (e.g., licensed physicians, psychologists, nurse practitioners, physician assistants, and social workers) are mandated to screen all incoming veterans for PTSD, depression, substance use, and suicidality. Mental and physical health screens are to be done on induction into VA care and yearly after that (34) . Healthcare providers are reminded to do the above health screens via a computerized notification system that is accessed during a patient care visit and requires that the provider address the notifications before the visit is finished. Mental and physical disease conditions were diagnosed by VA PCPs, according to the International Classification of Diseases and Related Health Problems, Revision 9 (ICD-9) and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition that were utilized for this study (4, 11) . Diagnoses were coded as disease presence or absence at every medical visit.
Mental Health
Three Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition mental health categories were examined: PTSD; depression; and substance use disorder. A PTSD diagnosis includes experiencing a traumatic event (e.g., combat, personal assault) and a response of intense fear, horror, or hopelessness; at least one or more symptoms of preoccupation or reexperiencing of the event; three or more symptoms of avoidance of the event (e.g., avoid thoughts and feelings regarding the event, feeling detached/estranged from others); two or more symptoms of hyperarousal (e.g., difficulty concentrating, sleeping, hypervigilance). A Depression diagnosis (we included individuals with one or more episodes of depression or mood disorder) is defined as: five or more symptoms present for Ն2 weeks that must include either depressed mood or loss of interest or pleasure (e.g., insomnia or hypersomnia, fatigue, feelings of worthlessness, diminished ability to think or concentrate). A diagnosis of a Substance Use Disorder includes the abuse or dependence on alcohol or illicit drugs (e.g., opiates, methamphetamines).
Physical Disease
Eight medical health categories were generated. To examine the association of PTSD with concrete (e.g., hypertension) and idiopathic disease conditions (e.g., ill-defined conditions), we examined conditions including: endocrine/nutritional/metabolic disease (e.g., thyroid, metabolic, and immune disorders); nervous/sense organs (e.g., headache, organic sleep and nerve disorders); circulatory disease (e.g., chronic pulmonary and ischemic heart disease); hypertension (e.g., hyperpiesia, cardiomegaly); respiratory disease (e.g., emphysema, asthma, pneumoconioses); digestive disease (e.g., colitis, hernia, and intestinal disease); musculoskeletal /connective disease (e.g., arthropathies, rheumatism); and signs and ill-defined conditions (e.g., hyperesthesia, cachexia, and dyspnea). Table 2 lists codes utilized for the diagnostic categories.
Statistical Methods
Our primary interest was to compare the timing of disease onset according to PTSD status among patients who did not have disease at the time of their first medical visit. Thus, patients who had hypertension at baseline were excluded from the hypertension analysis. This type of exclusion was done for each of the eight individual outcomes. Cox hazards regression was utilized to assess the time from the initial medical visit to PCP-assigned disease diagnosis according to PTSD status at the same time statistically controlling for potential confounding variables. All covariates were analyzed on their natural scale, except for marital status, which was collapsed into married versus not married due to small cell counts.
As the majority of PTSD diagnoses occurred after veterans' initial post deployment medical visit and because Cox regression accommodates predictor variables that change over time, we were able to incorporate disease status before and after a PTSD diagnosis. In other words, a patient diagnosed with PTSD during follow-up would contribute information to the hazard of disease before and after a PTSD diagnosis. This is a more efficient and valid assessment of a patient's disease trajectory as it covaries with PTSD compared with assessing disease onset according to PTSD status at a single moment (e.g., baseline) in time. For the same reasons, comorbid depressive and substance use disorders, conditions known to influence disease onset and progression, were also entered into our statistical model as time-varying covariates in order to assess the independent influence of these variables on physical disease development over time.
The hazard of disease can be interpreted as the likelihood of disease at a point in time given that disease has not yet occurred; results are frequently 
This equation states that the hazard for individual i, at time t, is the product of the baseline hazard ( o (t)) and a linear function of four fixed and three time dependent (PTSD, depression, substance abuse) covariates, which is exponentiated. Three of the four fixed covariates are dichotomous indicators used to compare the hazard of having the characteristic versus not (i.e., unit type: active versus reserve; married versus nonmarried; female versus male). Depression and substance use disorder are dichotomous but are not fixed covariates. Age at the baseline visit is the fourth fixed covariate entered into our model as a linear predictor of the log hazard of disease. As shown in the above equation, the effect of PTSD, depression, and substance use is indexed by t, indicating that the hazard at time t depends on these disorders, whereas the remaining variables are defined in the usual constant proportional hazards fashion. Finally, logistic regression analysis was implemented as an adjunct to the time to event analysis described above to determine if the prevalence of disease was in line with the time to onset results.
RESULTS
Demographic and Clinical Characteristics
On average, participants were 29 (SD ϭ 8) years of age and male (89%; n ϭ 3932). Most participants were never married (48%; n ϭ 2091) followed by those who were married (38%; n ϭ 1,700), divorced (9%; n ϭ 393), separated (4%; n ϭ 168), unknown (1%; n ϭ 37), widowed (0.2%; n ϭ 7). The majority of veterans were white (85%; n ϭ 3445), followed by black (8%; n ϭ 302), Hispanic (3%; n ϭ 138), or individuals of another racial category (2%; n ϭ 78). The sample was almost evenly split between Active Duty veterans (53%; n ϭ 2144) and Reserve/National Guard veterans (47%; n ϭ 1894) ( Table 1) .
At baseline, 277 (6%) of 4416 participants had a diagnosis of PTSD. During the study period, a total of 1031 (24.6%) participants were diagnosed with PTSD. The average follow-up period (i.e., time that the participant was in the study) was 17.3 months (SD, 18.8), ranging from 0 to 72 months. A participant was considered to have a follow-up period of 0 month if he/she entered the study with an initial visit to primary care but had no other visits before the end of the study period.
To examine how representative this sample of veterans to the population of OEF/OIF veterans using VA health care, we compared our sample to a national sample of veterans who are separated from active military and have enrolled in VA health care (12) ( Table 1 ). Due to our large sample size, small differences in characteristics, such as female gender (11% versus 12%) between our sample and the national average, translate into statistically significant effects. To capture the most comprehensive picture of the effects substance use disorders have on physical health outcomes, we included ICD-9 diagnoses of substance abuse as well as dependence, likely the reason for the higher rates substance use disorders in our sample compared with the national sample (10% versus 6%). Along those same lines, we combined ICD-9 diagnoses of depression and related mood disorders in our analyses, whereas the national sample separates these conditions. Rates of PTSD are higher in our sample and may be due to regional differences. Setting aside statistical differences due to sample size and coding, our sample demographics seemed to be representative of the population of OEF/OIF veterans seeking VA medical care. The similarities between these samples strengthen our hypotheses that patterns found in the current sample are comparable with patterns of disease common in post deployment OEF/OIF veterans.
PTSD and Physical Conditions
Logistic regression analyses showed that PTSD diagnosis was associated with increased odds of ever developing dis- Table 2 presents these results. Adjusting for theoretically relevant covariates known to influence disease risk (age, gender, marital status, depression, substance use disorders, and unit type), PTSD was associated with significantly increased risk of early onset physical disease (Fig. 1) . A diagnosis of PTSD was associated with a 56% increased risk of hypertensive disease (HR, 1.56, 95% CI, 1.19 -2.04), a 36% increased risk of circulatory disease (HR, 1.36, 95% CI, 1.11-1.67), a 24% increased risk of digestive disease (HR, 1.24, 95% CI, 1.08 -1.43), a 81% increased risk of nervous system disease (HR ϭ 1.81, 95% CI, 1.59 -2.06), a 49% increased risk of musculoskeletal disease (HR, 1.49, 95% CI, 1.32-1.67), and a 70% increased risk of ill-defined signs and symptoms (HR, 1.70, 95% CI, 1.51-1.92). PTSD was not associated with increased risk of endocrine/nutritional/metabolic or respiratory disease.
DISCUSSION
The results indicate that physical health effects are associated with PTSD in the early years post deployment among female and male OEF/OIF veterans. As hypothesized, veterans with a diagnosis of PTSD were at elevated risk of early-onset PCP-diagnosed hypertensive, circulatory, digestive, nervous system, musculoskeletal disease, and signs and ill-defined conditions. Results suggest that PTSD is a unique contributor to disease even after controlling factors known to have a significant impact on physical disease onset and severity (e.g., depressive and substance use disorders) (14, 36) . To our knowledge, this is to the first study to demonstrate that a diagnosis of PTSD is associated with increased prevalence of both concrete and ill-defined PCP-diagnosed disease among OEF/OIF veterans in the early post deployment years.
What is particularly striking about these findings is that diseases traditionally considered to develop across the lifespan (e.g., circulatory system and hypertensive conditions) (29, 30) appeared shortly after the end of military service. Unlike many studies that rely on self-reported PTSD symptoms and health (8) or lifespan data (25, 37, 38) , the results here suggest that a wide range of health outcomes associated with PTSD are apparent throughout the body within a relatively short time period.
Several theories outline a causal path between PTSD and physical disease development. Due to the persistent psychological symptoms associated with PTSD, individuals may experience maladaptive alterations along the hypothalamicpituitary-adrenocortical and sympathetic-adrenal-medullary stress axes (28, 39) . The theory of allostasis posits a continuing cost to multiple body systems to maintain homeostasis in the face of unremitting stress, such as PTSD (40) . For example, ongoing stress-related neurohormonal dysregulations influence physical disease onset and progression by disrupting core physiologic processes regulating blood pressure, glucose metabolism, immune response, and even gene expression (41) . Biological theories of PTSD suggest that the health-damaging effects are likely due to multiple factors (28, 42) . PTSDassociated hyperarousal may block the individual's parasympathetic system from performing the necessary reparative functions (e.g., digestion, lowering blood pressure). Additionally, the psychological and physiological resources required to cope with PTSD compete with demands imposed by stressors encountered in daily life, rendering an individual unable to mount an appropriate physiological response to new stressors, which creates susceptibility to future disease (28) . A person may have a preexisting combined vulnerability to both PTSD and disease (e.g., inadequate adrenal functioning and psychopathology) that, when exposed to environmental stressors, interact with biologic vulnerability to stimulate disease states (28) . Risky health behaviors, such as substance abuse and excessive caloric intake, are highly related to disease onset and severity and should be considered in PTSD-health link.
Limitations to this study include the following: Results may not be generalizable to veterans who are not enrolled in the VA healthcare system, or veterans using the VA healthcare system outside of Upstate New York. For example, the majority of veterans in our sample are white males, which is representative of veterans who enroll in VA health care post deployment in Upstate New York, but they may not be representative of the minority population in the military at large. ICD-9 medical diagnoses may be overdiagnosed or misclassified; unmeasured variables may be influencing the findings; and due to the study design, we are unable to determine causality. Research (43) has revealed that PTSD is underdiagnosed by PCPs within the VA system utilizing ICD-9 di- 
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agnostic criteria. The underdiagnosis of PTSD among our study sample would mean that there are individuals in our no-PTSD group who have PTSD. Based on our findings, these veterans would likely have greater rates of physical disease diagnoses. If there were a significant number of these cases in our data, it would work to wash out our effects, given the higher rate of disease among PTSD patients in our no-PTSD group. Thus, the outcomes discussed in this paper are a conservative estimate of the relationship between PTSD and physical disease.
Despite these study limitations, the data show a pattern of association between PCP-diagnosed PTSD and prevalence of early-onset physical disease in the first 5 years post trauma exposure. These findings are of particular importance, given that a requirement of military service is that soldiers enlist with good health and typically remain healthier than representative community samples for the duration of their service (44) .
In conclusion, our results suggest that PTSD diagnosis is associated with increased prevalence and early onset of PCPdiagnosed physical disease among OEF/OIF veterans within the early years post military service. The rising rates of PTSD diagnosis among OEF/OIF veterans may foreshadow a significant increase in lifespan morbidity, mortality, and healthcare utilization in the coming years. Rapid intervention for post deployment PTSD may be warranted to attenuate the impact of PTSD on health. Future work should examine whether empirically supported treatments for PTSD, such as Cognitive Behavioral and Prolonged Exposure Therapy (45, 46) and Cognitive Processing Therapy (47) , positively affect the health status of returning veterans.
